These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 33762145)

  • 1. Fostering MOUD use in justice populations: Assessing the comparative effectiveness of two favored implementation strategies to increase MOUD use.
    Molfenter T; Vechinski J; Taxman FS; Breno AJ; Shaw CC; Perez HA
    J Subst Abuse Treat; 2021 Sep; 128():108370. PubMed ID: 33762145
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Massachusetts Justice Community Opioid Innovation Network (MassJCOIN).
    Evans EA; Stopka TJ; Pivovarova E; Murphy SM; Taxman FS; Ferguson WJ; Bernson D; Santelices C; McCollister KE; Hoskinson R; Lincoln T; Friedmann PD;
    J Subst Abuse Treat; 2021 Sep; 128():108275. PubMed ID: 33483222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Scoping Review of Barriers and Facilitators to Implementation of Medications for Treatment of Opioid Use Disorder within the Criminal Justice System.
    Grella CE; Ostile E; Scott CK; Dennis M; Carnavale J
    Int J Drug Policy; 2020 Jul; 81():102768. PubMed ID: 32446130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Transitions Clinic Network: Post Incarceration Addiction Treatment, Healthcare, and Social Support (TCN-PATHS): A hybrid type-1 effectiveness trial of enhanced primary care to improve opioid use disorder treatment outcomes following release from jail.
    Howell BA; Puglisi L; Clark K; Albizu-Garcia C; Ashkin E; Booth T; Brinkley-Rubinstein L; Fiellin DA; Fox AD; Maurer KF; Lin HJ; McCollister K; Murphy S; Morse DS; Shavit S; Wang K; Winkelman T; Wang EA
    J Subst Abuse Treat; 2021 Sep; 128():108315. PubMed ID: 33583610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Strategies to recruit rural primary care providers to implement a medication for opioid use disorder (MOUD) focused integrated care model.
    Cloutier RM; Cole ES; McDonough BL; Lomauro DA; Miller JP; Talbert AL; Bear TM; Bridges NC; Foulds AL; Taber R; Gordon AJ; Cochran GT; Kmiec J; Donohue JM; Kelley D; DiDomenico E; Adair D; Pringle JL
    Implement Res Pract; 2023; 4():26334895231152808. PubMed ID: 37091535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Jail-based treatment for opioid use disorder in the era of bail reform: a qualitative study of barriers and facilitators to implementation of a state-wide medication treatment initiative.
    Krawczyk N; Bandara S; Merritt S; Shah H; Duncan A; McEntee B; Schiff M; Ahmad NJ; Whaley S; Latimore A; Saloner B
    Addict Sci Clin Pract; 2022 Jun; 17(1):30. PubMed ID: 35655293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of Project ECHO to promote evidence based care for justice involved adults with opioid use disorder.
    Adams ZW; Agley J; Pederson CA; Bell LA; Aalsma MC; Jackson T; Grant MT; Ott CA; Hulvershorn LA
    Subst Abus; 2022; 43(1):336-343. PubMed ID: 34283701
    [No Abstract]   [Full Text] [Related]  

  • 8. Availability of best practices for opioid use disorder in jails and related training and resource needs: findings from a national interview study of jails in heavily impacted counties in the U.S.
    Scott CK; Grella CE; Dennis ML; Carnevale J; LaVallee R
    Health Justice; 2022 Dec; 10(1):36. PubMed ID: 36538121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kentucky Women's Justice Community Opioid Innovation Network (JCOIN): A type 1 effectiveness-implementation hybrid trial to increase utilization of medications for opioid use disorder among justice-involved women.
    Staton M; Webster JM; Leukefeld C; Tillson M; Marks K; Oser C; Bush HM; Fanucchi L; Fallin-Bennett A; Garner BR; McCollister K; Johnson S; Winston E
    J Subst Abuse Treat; 2021 Sep; 128():108284. PubMed ID: 33455828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An ethical analysis of medication treatment for opioid use disorder (MOUD) for persons who are incarcerated.
    Brezel ER; Powell T; Fox AD
    Subst Abus; 2020; 41(2):150-154. PubMed ID: 31800376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Scoping review of interventions to link individuals to substance use services at discharge from jail.
    Grella CE; Ostlie E; Watson DP; Scott CK; Carnevale J; Dennis ML
    J Subst Abuse Treat; 2022 Jul; 138():108718. PubMed ID: 35012792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Facilitators and barriers to adopting or expanding medications for opioid use disorder provision in rural Colorado jails: a qualitative analysis.
    McNeely HL; Schreiber TL; Swann WL; Amura CR
    Health Justice; 2024 Jun; 12(1):26. PubMed ID: 38842589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Examining use of telehealth in jails: linking women to community OUD services.
    Staton M; Levi M; Winston E; B Oser C; Fallin-Bennett A; Dickson M; Matthew Webster J; Leukefeld C; Tillson M
    BMC Womens Health; 2024 Oct; 24(1):549. PubMed ID: 39367439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recovery support specialists inside the jail: a program description of treatment engagement for opioid use disorder.
    Martin M; Phillips MA; Saxon M; Love K; Cessna L; Woodard DL; Page M; Curry K; Paone A; Pennington-Stallcup B; Riley W
    Int J Prison Health; 2021 Nov; 17(4):497-508. PubMed ID: 38902903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Justice community opioid innovation network (JCOIN): The TCU research hub.
    Knight D; Becan J; Olson D; Davis NP; Jones J; Wiese A; Carey P; Howell D; Knight K
    J Subst Abuse Treat; 2021 Sep; 128():108290. PubMed ID: 33487517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessing the impact of drug courts on provider-directed marketing efforts by manufactures of medications for the treatment of opioid use disorder.
    Andraka-Christou B; Nguyen T; Bradford DW; Simon K
    J Subst Abuse Treat; 2020 Mar; 110():49-58. PubMed ID: 31952628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rationale, design and methods of VA-BRAVE: a randomized comparative effectiveness trial of two formulations of buprenorphine for treatment of opioid use disorder in veterans.
    Petrakis I; Springer SA; Davis C; Ralevski E; Gu L; Lew R; Hermos J; Nuite M; Gordon AJ; Kosten TR; Nunes EV; Rosenheck R; Saxon AJ; Swift R; Goldberg A; Ringer R; Ferguson R
    Addict Sci Clin Pract; 2022 Jan; 17(1):6. PubMed ID: 35101115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of a jail-based treatment decision-making intervention on post-release initiation of medications for opioid use disorder.
    Banta-Green CJ; Williams JR; Sears JM; Floyd AS; Tsui JI; Hoeft TJ
    Drug Alcohol Depend; 2020 Feb; 207():107799. PubMed ID: 31865058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stepped Care for Opioid Use Disorder Train the Trainer (SCOUTT) initiative: Expanding access to medication treatment for opioid use disorder within Veterans Health Administration facilities.
    Gordon AJ; Drexler K; Hawkins EJ; Burden J; Codell NK; Mhatre-Owens A; Dungan MT; Hagedorn H
    Subst Abus; 2020; 41(3):275-282. PubMed ID: 32697170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Syringe service program-based telemedicine linkage to opioid use disorder treatment: protocol for the STAMINA randomized control trial.
    Watson DP; Swartz JA; Robison-Taylor L; Mackesy-Amiti ME; Erwin K; Gastala N; Jimenez AD; Staton MD; Messmer S
    BMC Public Health; 2021 Mar; 21(1):630. PubMed ID: 33789642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.